United States

People: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

23 Sep 2016
Change (% chg)

$-1.52 (-1.97%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Maraganore, John 

Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of the Company. Dr. Maraganore also served as our President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development for Millennium Pharmaceuticals, Inc., a biopharmaceutical company (now a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited). He also serves as a director of Agios Pharmaceuticals, Inc., bluebird bio, Inc. and the Biotechnology Industry Organization, a non-profit biotechnology trade organization, and formerly served as a director of Regulus Therapeutics Inc.

Basic Compensation

Total Annual Compensation, USD 1,130,040
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 7,131,110
Fiscal Year Total, USD 8,261,160

Options Compensation

  Quantity Market Value
Exercisable 764,108 7,795,030.00
Unexercisable 357,206 2,292,970.00
Exercised 127,943 11,663,000.00